BACKGROUND: Epinephrine autoinjectors provide life-saving therapy for individuals with peanut allergies. OJECTIVE: To evaluate the association between socioeconomic status (SES) and epinephrine prescription among urban Canadian children with peanut allergy. METHODS: Population-based survey data from school children in grades 1 and 2 participating in the Toronto Child Health Evaluation Questionnaire were used. Children with peanut allergy, their epinephrine autoinjector prescription status and their SES were identified by parental report. RESULTS: Between January and April 2006, 5619 completed questionnaires from 231 Toronto, Ontario, schools were returned. A total of 153 (2.83%) children were identified as having a peanut allergy, 68.6% of whom reported being prescribed an epinephrine autoinjector. Children from upper-middle and high-income homes (OR 8.35 [95% CI 2.72 to 25.61]) and with asthma (OR 4.74 [95% CI 1.56 to 14.47]) were more likely to report having an epinephrine prescription. CONCLUSION: A significant health disparity exists in the prescribing pattern of epinephrine autoinjectors for peanut-allergic children from families of differing SES.
BACKGROUND:Epinephrine autoinjectors provide life-saving therapy for individuals with peanutallergies. OJECTIVE: To evaluate the association between socioeconomic status (SES) and epinephrine prescription among urban Canadian children with peanutallergy. METHODS: Population-based survey data from school children in grades 1 and 2 participating in the Toronto Child Health Evaluation Questionnaire were used. Children with peanutallergy, their epinephrine autoinjector prescription status and their SES were identified by parental report. RESULTS: Between January and April 2006, 5619 completed questionnaires from 231 Toronto, Ontario, schools were returned. A total of 153 (2.83%) children were identified as having a peanutallergy, 68.6% of whom reported being prescribed an epinephrine autoinjector. Children from upper-middle and high-income homes (OR 8.35 [95% CI 2.72 to 25.61]) and with asthma (OR 4.74 [95% CI 1.56 to 14.47]) were more likely to report having an epinephrine prescription. CONCLUSION: A significant health disparity exists in the prescribing pattern of epinephrine autoinjectors for peanut-allergic children from families of differing SES.
Entities:
Keywords:
Epidemiology; Health disparities; Peanut allergy; Socioeconomic status
Authors: Paul J Hannaway; Mary Ellen Connelly; Roberta M Cobbett; Paula J Dobrow Journal: Ann Allergy Asthma Immunol Date: 2005-08 Impact factor: 6.347
Authors: Sharon D Dell; Richard G Foty; Nicholas L Gilbert; Michael Jerret; Teresa To; Stephen D Walter; David M Stieb Journal: Can Respir J Date: 2010 Jan-Feb Impact factor: 2.409
Authors: Rhoda S Kagan; Lawrence Joseph; Claire Dufresne; Katherine Gray-Donald; Elizabeth Turnbull; Yvan St Pierre; Ann E Clarke Journal: J Allergy Clin Immunol Date: 2003-12 Impact factor: 10.793
Authors: Anita L Kozyrskyj; Matthew E Dahl; Dan G Chateau; Garey B Mazowita; Terry P Klassen; Barbara J Law Journal: CMAJ Date: 2004-07-20 Impact factor: 8.262
Authors: Joanna S Cohen; Chisom Agbim; Michael Hrdy; Mary E Mottla; Monika K Goyal; Kristen Breslin Journal: Allergy Asthma Proc Date: 2021-03-01 Impact factor: 2.587
Authors: Elissa M Abrams; Alexander G Singer; Lisa Lix; Alan Katz; Marina Yogendran; F Estelle R Simons Journal: Allergy Asthma Clin Immunol Date: 2017-11-10 Impact factor: 3.406